Certain former operations in capacitor manufacturing resulted in extensive direct contact of the workers with electrical grade polychlorinated biphenyls (PCBs). A study group of 194 such individuals, all exposed to Aroclor 1016 and many previously exposed to Aroclors 1242 and/or 1254, was examined before (1976) and after (1979) discontinuance of PCB use in the operations (1977). At the two examinations, the approximate geometric mean serum levels (in ppb) and 5 to 95% ranges were for lower PCBs (LPCB), 363 (57-2270) and 68 (12-392); and for higher PCBs (HPCB), 30 (6-142) and 19 (4-108), respectively.
Introduction
Concern over the human health effects of the polychlorinated biphenyls (PCBs) arises because of the environmental persistence of these substances, which were widely used in the U.S. for nearly 50 years . Several hundred million pounds still remain in existence, either in electrical equipment or in environmental compartments such as landfills, spillage sites or aquatic sediments (1) , so that the potential for human exposure continues.
The main growth of PCB usage occurred only after early toxicological studies and extensive industrial experience indicated these materials to be of relatively low toxicity (2) (3) (4) (5) . In the 1970s, however, PCBs were linked to an outbreak of severe chloracnegic disease in southwestern Japan in 1968. The outbreak was traced *General Electric Research and Development Center, P 0. Box to the ingestion of rice oil (Yusho) that had been contaminated with thermally decomposed PCB. The toxic agents responsible for "Yusho disease" were ultimately identified as 2,3,4,7,8-pentachlorodibenzofuran and other polychlorinated dibenzofurans (PCDFs) (6) , which are formed from PCBs only at very high temperatures (7) . Despite contrary evidence, concern has remained that ordinary, unpyrolyzed PCBs, even at residual environmental concentrations, might also produce some human health effects. In order to identify such effects, a number of epidemiological investigations have been performed on occupationally (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) or environmentally (20-22) exposed populations. All such studies have indicated PCB-related health effects in the human to be uncommon, and the only reasonably consistent findings to be statistical associations between the levels of serum PCBs and those of serum lipids, e.g., triglycerides and cholesterol (13, 15, 21, 22) . These associations have been interpreted as suggestive of otherwise asymptomatic alterations in liver function.
This interpretation did not recognize that in the body PCBs are partitioned between adipose tissue (the major reservoir) and blood serum in proportion to the lipid content of the serum (23, 24) . Therefore, statistical associations of serum PCBs with serum lipids and any covariant parameters could arise solely from such partitioning. In order to determine whether PCBs actually do have any effect upon serum lipid levels, it would be necessary to examine the dependence of the latter, not upon the levels of PCB in the serum, but instead upon their levels within the body lipids. For lipid-soluble materials, the concentration within the body's lipid phases has long been recognized as the determinant ofthe pharmacological response (25) . In addition to the consistently observed association between the levels of PCBs and lipids in the serum, there have been isolated reports of hypertension (22) , hepatomegaly (14) , chloracne (14, 22) , other dermal effects (12) (13) (14) , oxidase induction (16) , restrictive lung disease (18) , increased levels of serum -y-glutamyl transpeptidase (14, 15, 22) , serum glutamic oxalacetic transaminase (13) (14) (15) , serum glutamic pyruvic trans aminase (12, 14) , serum ornithin-carbamoyl transferase (14) , or serum pseudocholine esterase (14) , increased bromsulphthalein retention (12) , or reduced plasma HDL cholesterol (15) in the groups studied. Most such reports, however, either lack consistency with the findings of other investigators, or were observed only in groups that were small, lightly exposed to PCBs, and/or exposed to PCBs in combination with other chemicals.
An opportunity to study the effects of unpyrolyzed, electrical grade PCB exposure has been provided at two capacitor manufacturing plants located within a mile of each other along the Hudson River in upstate New York. During their period of PCB use , these plants are believed to have been the largest single U.S. users, consuming about 15% of all U.S. production, and to have had one of the largest PCB-exposed work forces. Between 1946 and , approximately 9500 different employees worked there, and the employment during the [1976] [1977] [1978] [1979] period of this study was between 1500 and 1800.
Previous investigators of this plant population have found its mortality experience (reported as that for "Plant 2" by Brown and Jones) (19) to be normal for all major causes of death, and have indicated a general paucity of significant clinical effects in a volunteer sample drawn from the plant population as a whole (17) . However, only 5 to 10% of the plant employees worked in areas or jobs providing direct, continuing exposure to the dielectric fluids. Thus, it appeared probable that this exposed subpopulation, still a sizeable group, might exhibit considerably greater blood PCB levels and physiological effects than the remainder of the plant population.
Accordingly, a study population was selected, using criteria that were broad enough to include the entire directly exposed group, as well as some less directly exposed individuals, and detailed clinical examinations were performed approximately 16 months before and 29 months after the discontinuance of PCB use in the plant. No attempt was made to establish a comparable age-and sex-matched control cohort, but since the study group itself exhibited a distribution of PCB levels covering over two orders of magnitude, analyses within the group offered adequate prospects for identifying and quantifying physiological effects attributable to the PCBs.
Since it was not possible, initially, to decide which of the many clinically measured varaiables might be affected by PCBs or might confound the study, a threetiered analysis was used to identify statistically significant associations. In order, these analyses were: (a) a simple linear regression, intrinsically bias-free, for each measured variable or its log transform against each measure of PCB exposure; (b) a multiple linear regression for each of the measured variables against the selected measures of PCB exposure and a series of other independent variables, e.g., sex, age, smoking history, body mass index, etc., believed to have effects on one or more of the clinical variables and (c) a backward stepwise linear regression to remove non significant independent variables. For each regression, statistically significant associations (p < 0.05) with the measures of PCB were identified. In addition, the 95% confidence limits of the regression coefficient were used to estimate the significance of the association over the observed range of exposure. Similar regressions were performed for the same measures of p,p'-DDE, which shares with PCBs partitioning behavior in lipids.
Materials and Methods

Description of Environment
In the process used for manufacturing liquid dielectric capacitors, metal foil strips separated by paper layers were wound into tight coils and inserted into metal cans. A cover assembly, having electrical connectors and a port to admit the dielectric fluid, was then sealed to the can. For filling, small capacitors, such as those used in fluorescent light ballasts, were packed onto racks that were placed in large autoclaves, warmed, degassed under vacuum, and then flooded with the dielectric fluid. The racks were then drained, removed, and transported to sealing stations where the port was manually sealed with solder. Large power capacitors were originally filled manually; subsequently, they were filled by an electronically controlled manifold system which reduced spillage and dermal contact. Following sealing, both large and small capacitors were cleaned, degreased, tested, repaired if appropriate, labeled, and packed for shipment. The dielectric fluids were blended with stabilizers, treated with fuller's earth to remove polar impurities, and tested for dielectric properties, thereby producing an "electrical grade" product. The jobs which provided frequent or continuous direct exposure to the dielectric fluids (i.e., direct dermal contact and/or close proximity to a source of vapor) were those associated with the fluid processing, the handling and sealing of wet capacitors, capacitor salvage and repair, and the quality control laboratory.
Aroclor 1254, a commercial mixture of PCB isomers and homologs having the average molecular composition of a pentachlorobiphenyl, was used initially in the two plants (1946 (17) . By the time of our 1979 examination, our directly exposed study group was reduced to 174 workers due to relocation, although still including 14 retired and/or relocated workers who returned for the reexamination.
At the time of the initial population selection an estimate of the relative PCB exposure was made by one of us (M. R.) on the basis of the individual worker's job activities. The estimated exposure categories (abbrevi ated as EXE below) generally corresponded to those used for selection, e.g., "low" for peripherally exposed jobs; "medium" for those with intermittent exposure; and "high" for those with continuous direct exposure. After the serum PCB data became available, analysis showed that the "low" and "medium" categories were statistically indistinguishable in terms of serum PCB means.
Clinical Measurements
The clinical examinations were conventional but relatively complete. They included a medical history, physical examination by the plant physician (J.F.), ECG, chest X-ray, spirometry, 26-parameter biochemical analysis, hematology, and urinalysis. Body weight was measured in light indoor clothing and height measured without shoes. Systolic and diastolic blood pressure were measured in the seated position to the nearest 5 mm. The participants were instructed to be fasting for the preceding 12-hr period with water ad libitum.
The decision to measure serum PCB levels in 1976 was made during the course of the study, so that only 41 workers had the blood samples required for the PCB analysis drawn while fasting; the remainder were recalled and sampled in the nonfasting state. All of the 1979 measurements were made on fasting sera.
In 1979, the physical examination, ECG, and chest X-ray were repeated only in special cases, but the medical history was expanded and improved, particu larly in relation to smoking habits. Documentation on alcohol consumption remained incomplete and generally unreliable.
The chest X-rays were read by a local radiologist (R. C. Batt) who coded the findings according to the ILO/UC criteria (CRC/NIOSH (M) 2 (27) .
These procedures also provided data on the levels of DDE present. The observed distributions of PCB isomer peaks in the capacitor workers' chromatograms are also described elsewhere (27) Because of the differences in PCB composition between the serum samples and the standards, such values overstate the amounts of PCB actually present. The latter are now more commonly described in terms of values for LPCB ("lower PCBs," i.e., all isomers having gas chromatographic retention times on silicone less than that of DDE, which comes in the middle of the pentachlorobiphenyl range), and HPCB ("higher PCBs," i.e., those with retention times > DDE) with the sum of LPCB and HPCB representing the total PCB present (TPCB). We have shown elsewhere (27) 
Results
Clinical Characteristics of the Study Population
The medical history and physical examination of the study population revealed a variety of clinical conditions and health-related practices.
Sixty-five percent of the population were smokers or ex-smokers, and 26 workers (17%) showed obstructive patterns on repeated spirometric testing. There were six chest X-ray reports of possible emphysema. 
Clinical Laboratory Findings
The distributions of clinical chemical and hematological values observed in the study population are described in Table 1 , along with the normal ranges unadjusted for sex and age, and asterisks indicating variables having values outside these rough reference ranges.
The numbers of individuals reported by the clinical laboratory to be outside its internal age-and sex-adjusted standards (based on ± 2 standard deviations from mean values) are listed for each reported parameter in Table 2 . If the parameters were normal and normally distributed, one would expect four or five cases to fall along each tail of these distributions, making a total of eight to ten. fell outside the 95th percentile for age from the Lipid Research Clinics Prevalence Study (31) . By the LRCP study criteria, the portions of the male population exhibiting elevations in triglycerides in 1976 and 1979 were 5.7% and 12.6%, respectively. This elevation was significant at the 1% level by paired t-test. For females, the elevation in triglycerides was significant at the 5% level but was found in the younger women and appeared to be related in part to obesity and estrogen medication. Of unknown significance were the differences in analytical methodology (fluorimetric method with Technicon Autoanalyser used by LRCPS; enzymatic method with discrete analyser used here). The serum cholesterol values (Fig. 2) Measures of PCB Exposure Table 3 shows the means and ranges for serum PCB concentrations described in four ways: first as the Ar- 
Relationships of Independent Variables to PCB Exposure
The correlation coefficients for the association of the individual independent variables selected for the re association in one of the six regressions performed. The where the regression coefficient was found to be of statest of significance was that the 95% confidence interval tistical significance, which, depending on the number of for A , not include zero; statistically significant associa degrees of freedom, generally corresponded to a partial tions are indicated by asterisks. In addition, in Tables r > 0. 15; in addition, we have listed some borderline 6-8 we have listed the partial r values for the backward associations, as indicated by partial r values of 0.14-step regressions against the log serum lipid xenobiotic 0.15. A comparison ofthe I , B values across these various (e.g., LPCB, HPCB or DDE) and the other independent regressions indicates the sensitivity of the relation to variables. The partial r values listed are generally those confounding by the other independent variables, and The most consistent finding in Tables 6-9 was the strong, positive associations of log serum triglycerides and cholesterol with the log gross serum level of PCBs and DDE which has been found by others (13, 15, 21, 22 Tables 6-9 showed at least one significant association (5% level) with one measure of exposure in one of the regressions for 26 of the 42 clinical variables. The incidence of significant associations with the clinical variables was positively influenced by the number of independent variables included in the regressions. The independent variables used in Tables 6-9 regressions all showed multiple associations with the clinical laboratory parameters. This group of independent variables did not, however, include measures of alcohol consumption or socioeconomic status, both of which have been used in other studies (21, 22) . The data available indicates that there can be important colinearities among the dependent variables. Because of the uncertainties presented by chance associations, unused or unidentified confounders, and colinearities among variables we have focussed our interpretations upon those associations that were seen consistently in the step regressions against log serum lipid PCBs, but not in the corres ponding regressions against log DDE.
The mean I coefficients of Tables 6-9 express the best estimates of the dependence of the clinical laboratory variables on log PCB, and their 95% confidence limits indicate the uncertainties of these estimates. For associations observed to be statistically significant we have multiplied the lower and upper P, confidence limit values by the observed range of log PCBs in order to determine whether the product resulted in values for the laboratory variables outside the normal expected (33) . For the log total bilirubin data of Figure 3 , the partial r was -0.22 (p = 0.01) and I3 about -0.09 log units/decade of LPCB (Table 6 ). For 2.2 decades of LPCB, the range of the P, product was -0.07 to -0.33 (mean = -10.2).
When controlled for confounders, all study data (Fig.  3 ) fell between 0.1 and 1.0 mg/dL (mean = 0.3 mg/dL), which is within the normal range ( Table 1) . As shown in Figure 4 the 1979 percent monocyte data were more tightly grouped (partial r = 0.28), and the I,3 estimate was 1.38%/LPCB decade. For the 2.5 decade range of LPCB, the range of 3 , B products corresponded to an increment in percent monocytes of 1.8 to 6.2% (mean = 3.5%). Inspection of the histogram along the monocyte axis indicates a range of percent monocytes from 5.5 to 15.5% (mean = 10.5%) rather than the normal range of 0 to 8% (Table 1) .
Discussion
PCB Levels in the Study Population
This investigation has shown that certain former operations in capacitor manufacturing presented high exposures to PCBs, particularly during the 1954-1977 period when the more volatile lower PCBs (Aroclor 1242 and 1016) were in extensive use. During this period PCB air levels in the affected working areas were probably at least the 690 ,ug/m observed in 1975, accompanied by extensive dermal contact as well.
In our study population, selected so as to include those working in or near the plant PCB exposure zone, the mean serum lipid LPCB level in 1976 (Table 3) was estimated to be 93 ppm (5-95% range, 15-560 ppm), adjusted for a factor of 10 analytical error. This serum lipid value corresponded to a mean body burden of 2.0 g (0.3-12.3 g) for the population mean body weight of 77 kg (22 kg of fat). These retained LPCBs were com- aSee Table 6 footnotes. posed primarily of penta-and hexachlorobiphenyl iso-
The mean serum HPCB level in 1976 was estimated mers (27, 34, 35) resulting either from exposures to to be 8 ppm (2-34 ppm), corresponding to a mean body Aroclor 1242 (which contained a few percent of the lower (Table 3) . We have shown elsewhere that the minimum initial concentrations of Aroclors 1016 plus 1242 required to account for the most persistent LPCB peaks were about 7.5 times the residual LPCB levels (27) . Thus, the minimal LPCB uptake by the study population may be estimated as 15 g (2.5-92 g). This estimated uptake is a minimum since even the most persistent LPCB peaks have a finite clearance rate (unpublished observations). The longer service employees could have absorbed several times this minimal PCB uptake, but until better data on PCB clearance becomes available, actual cumulative LPCB uptakes cannot be estimated more precisely.
The mean LPCB body burden in 1979 (29 months after discontinuance of major exposure) was estimated as 0. error band of the analytical technique (27) and a conclusion of significant clearance is probably unwarranted. Chen (35) has reported clearance rates for various pentachlorobiphenyl isomers in Taiwanese Yusho patients that appear to be at least 10-fold greater than we observed in capacitor workers (27) ; however, such clearance might be related to P-448 oxidase induction by PCDFs in the Yusho patients. Although these estimates of PCB fat levels and uptakes are only approximate, they serve to define the dose ranges within which the observed responses can be ascribed.
PCB Effects on Serum Lipids and Serum Enzymes
Previous investigators have reported statistical associations between log gross serum levels of PCBs and the serum levels of triglycerides, total cholesterol and certain serum enzymes. Our findings were in general agreement with such reports. We found significant associations of log serum triglycerides and total choles- terol with every measure of log gross serum PCBs and DDE in the final step regressions. Similar associations were found for log GGTP, and in some cases for log SGPT, with log gross serum PCBs, and for log alkaline phosphatase with log gross serum DDE.
It is now evident, however, that such associations arise because the level of PCBs in the serum is itself determined by that of the serum lipids (23, 24) . When the PCB concentrations were expressed as levels in serum lipids, which would be expected to correlate with the pharmacological activities (24, 25) , all the associations between serum lipids or enzymes and log gross serum LPCB, HPCB or DDE disappeared except for those between log GGTP and log PCBs, and between log alkaline phosphatase and log DDE. Similarly, Chase et al. (13) , who reported associations with gross serum PCBs, found no significant correlation between either serum triglycerides or SGOT and the adipose tissue fat biopsy PCB levels. Although elevated levels of serum triglycerides, total cholesterol and SGPT were found in our study population (Table 3) , serum GGTP levels were generally in the normal range, and the regression studies indicated stronger associations with obesity (body mass index).
PCB Effects on Microsomal Enzymes
Elevated serum GGTP levels have been prominently mentioned in the literature as an index of microsoinal enzyme induction in the human (36) (37) (38) (39) (40) . Recent studies (41), however, have in part disputed this conclusion. In their review of environmental hepatic injury, Popper et al. (42) found only meager evidence of substantiated chronic hepatic effects. They concluded that conventional liver function tests were of limited value in detecting hepatic abnormalities and that the evidence so far indicates that too many other processes influence GGTP activity in man to make it a useful index of induction. The clinical implications of elevated GGTP levels in man are reviewed by Guzelian elsewhere in this symposium.
However, the interpretation of the relationship between serum GGTP and serum lipid PCBs as evidence of microsomal enzyme induction is strengthened by the finding of strong inverse statistical associations between both direct and total bilirubin levels and serum lipid PCBs in 1976 during the period of active PCB exposure. A weak residual association between serum lipid HPCB and direct bilirubin (partial r = 0.14) was found in 1979 when the mean total bilirubin (mostly unconjugated) had risen from 0.46 to 0.61 mg/dL without change in the mean direct bilirubin (conjugated form) ( Table 1) .
Since the original observations of Yaffe et al. (43) on the therapeutic use of phenobarbital to enhance glucuronide-conjugating capacity in infant hyperbilirubinemia, a substantial literature has developed linking drugs (36, 44) and other xenobiotics (45, 46) to induction of microsomal enzymes, including enhanced glucuronyl transferase, resulting in increased conjugation and accelerated hepatic elimination of bilirubin. D-Glucaric acid is the main excretory product of the glucuronic acid conjugation pathway and its urinary level also has been advocated as a measure of enzyme induction (47) (48) (49) (50) . Drugs and chemicals inducing microsomal enzymes are often metabolized by the induced oxidases (32) , and it appears likely that such induction would accelerate clearance of PCBs as well as bilirubin (49, 51) .
Hirayama et al. (52) reported serum total bilirubin levels of 0.87 ± 0.33 mg/dL in 257 normal controls and 0.48 ± 0.26 mg/dL in 121 Yusho patients, indicating a 46% decrease in the latter. However, the observations were made at a time when the PCB levels had declined to background values, so that the pharmacologically active agents present were probably the PCDFs. Induction of glucuronyl transferase by Aroclor 1242 and 1016 has been reported in rats (16, 53) , as has also that of demethylases (16, 53) , aniline hydroxylase, (53) and cytochrome P-450 (16, 53) , but not that of the P-448 cytochrome (16) . Burse et al. (54) have shown that rats fed 100 ppm of Aroclor 1242 or 1016 (3.9-6.6 and 3.5-6.9 mg/kg! day) reach equilibrium adipose tissue fat concentrations of 35 to 143 or 69 to 236 ppm, respectively, at 6 months, levels in the range of those observed in this study (Table   3 ). Similar levels in rats were also reported by Goldstein et al. (53) , who found a 3-and 12-fold increase in liver glucuronyl transferase activity with Aroclors 1016 and 1242, respectively.
The most compelling evidence for microsomal enzyme induction in man is a response to drug administration (42) . In 1977, Alvares et al. (16) 
PCB Effects on Hematological Parameters
The findings of significant associations between log serum lipid PCBs and some hematolotical variables was unexpected because Maroni et al. (14) reported normal hematology including WBCs and differentials and no abnormal reports in occupationally exposed PCB workers have been mentioned by others (11) (12) (13) 15, 17 (Tables 1 and 2 ), the statistical association of serum PCB levels and the monocyte counts was strong.
Because of the absence of a monocytosis in 1976, its lack of association with either DDE or total or direct bilirubin in 1979, and its absence among retirees in 1979, we hypothesized that the effect might be related to a new exposure in the workplace, perhaps to the PCBsubstitute dielectric. However, we recently studied 54 workers with no prior PCB exposure who were currently exposed to the substitute and found no monocyte elevations. Although a number of solvents were in use in the environment in 1979, the monocytosis was mild compared to that observed by Minot and Smith (55) in the case of tetrachlorethane exposure, where the monocyte levels were elevated 20 to 40%. The effect of the change from the manual (1976) to automated differential analysis (1979) is unknown. We have also hypothesized that the monocytosis observed in 1979 might be related to the increased incidence of chronic obstructive lung disease, heavy smoking or concurrent respiratory infections. We are currently studying the associations between the spirometric variables (FVC, FEV, FEV/ FVC) and the hematological parameters in the study population and are restudying the entire population, which should cast further light on any such relationships.
Clinical Consequences of PCB Exposure
These findings differ from those of most other recent studies of environmentally or occupationally exposed populations in offering evidence of microsomal enzyme induction, which is consistent with the extensive LPCB clearance also observed in these highly exposed workers. The evidence is statistical in nature and the associated parameters remained within their normal clinical ranges, except possibly for the lymphocytes in 1976 and the monocytes in 1979. The effects were therefore physiological rather than pathological and appeared to subside following the cessation of PCB use. The long-term consequences of such enzyme induction are obscure (42) .
The present clinical health of the study population appears to meet community medical standards. Despite the prevalence of cardiovascular risk factors (obesity, elevated cholesterol levels, smoking, etc.) the mortality experience has been normal. The paucity of clinical abnormalities is consistent with laboratory studies in rats involving chronic administration of Aroclor 1242 and 1016, producing tissue fat levels comparable to the serum lipid PCB levels observed here. Such studies (54) have shown no overt symptoms of clinical poisoning and no pathological evidence of liver damage. The production of serious liver damage in rats (56) requires the use of a largely nonmetabolizable PCB, such as Aroclor 1260, at a cumulative dose of 2.5 g/kg, which would result in tissue lipid HPCB levels above 10,000 ppm, as compared to those in our study population of 8 ppm in 1976 and 5 to 6 ppm in 1979. It is evident, therefore, why the serious hepatic effects in the test rat could not be observed in man.
